Clopidogrel Use Is Associated With an Increased Prevalence of Cerebral Microbleeds in a Stroke‐Free Population: The Rotterdam Study

BACKGROUND: Although clopidogrel reduces the incidence of atherothrombotic events, its use is associated with an increased risk of major bleeding. Cerebral microbleeds (CMBs) are indicative of subclinical microangiopathy in the brain and may prelude symptomatic intracerebral hemorrhage. We examined...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Darweesh, Sirwan K.L., Leening, Maarten J.G., Akoudad, Saloua, Loth, Daan W., Hofman, Albert, Arfan Ikram, M., Vernooij, Meike W., Stricker, Bruno H.
Format: Artigo
Jezik:Inglês
Izdano: Blackwell Publishing Ltd 2013
Teme:
Original Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3835244/
https://ncbi.nlm.nih.gov/pubmed/24072532
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.113.000359
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items